closedosingdownloadefficacymoasafetytable-checktable-cross

The OTEZLA® international website

This site is intended for healthcare professionals outside the U.S.

A different way to see psoriatic arthritis

Discover how PDE4 inhibition regulates the immune response in the body, believed to cause inflammation in psoriatic arthritis

About psoriatic arthritis1

Psoriatic arthritis is a systemic imunomediated disorder characterized by inflammation of joints, surrounding ligaments and tendons, and psoriatic skin lesions.1

Psoriatic arthritis has a significant negative impact on patient functionality, psychology, and quality of life. In one study, psoriatic arthritis was significantly associated with reduced work productivity.2-5

Many patients are diagnosed with psoriatic arthritis approximately 10 years after initial skin symptoms develop.6

Where can I find more information and support?

References:

  1. Gottlieb A et al. J Am Acad Dermatol. 2008;58:851-864.
  2. Husted JA et al. J Rheumatol. 2013;40(8):1349-1356.
  3. Tillett W et al. Rheumatology (Oxford). 2012;51(2):275-283.
  4. Lee S et al.P T. 2010;35(12):680-689.
  5. Singh JA et al. J Rheumatol. 2009;36(5):1012-1020.
  6. Winterfield LS et al. Ann Rheum Dis. 2005;64 Suppl 2:ii87-ii90.
You are leaving the OTEZLA® (apremilast) website
Do you wish to leave this site?
OTEZLA International Websites
OTEZLA is approved in 51 Countries
  • United States

  • Canada

  • Australia

  • Israel

  • Switzerland

  • New Zealand

  • Austria

  • Belgium

  • Bulgaria

  • Croatia

  • Republic of Cyprus

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • France

  • Germany

  • Greece

  • Hungary

  • Ireland

  • Italy

  • Latvia

  • Lithuania

  • Luxembourg

  • Malta

  • Netherlands

  • Poland

  • Portugal

  • Romania

  • Slovakia

  • Slovenia

  • Spain

  • Sweden

  • United Kingdom

  • Norway

  • Iceland

  • Liechtenstein

  • Russia

  • Japan

  • Hong Kong

  • Singapore

  • Kuwait

  • Taiwan

  • UAE

  • Korea

  • Thailand

  • Lebanon

  • Qatar

  • Argentina

  • Mexico

  • Brazil